Biol Reprod
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by KIRTON, K. T.
Right arrow Articles by FORBES, A. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by KIRTON, K. T.
Right arrow Articles by FORBES, A. D.
Agricola
Right arrow Articles by KIRTON, K. T.
Right arrow Articles by FORBES, A. D.

Biology of Reproduction, Vol 3, 163-168, Copyright © 1970 by Society for the Study of Reproduction

Some Effects of Prostaglandins E2 and F2agr on the Pregnant Rhesus Monkey

K. T. KIRTON 1, B. B. PHARRISS 1, , and A. D. FORBES 1

1 Fertility Research, The Upjohn Company, Kalamazoo, Michigan 49001


Prostaglandin E2(PGE2) or prostaglandin F2agr (PGF2agr) was injected subcutaneously or infused intravenously into pregnant rhesus monkeys. Animals were between day 30 and 127 of pregnancy; pregnancy termination, serum progestin levels, and uterine contractility were parameters measured to determine efficacy. Subcutaneous injections of PGF2agr or PGE2 terminated pregnancy in 8 of 13 animals when given between day 30 and 41 and beyond day 100 of pregnancy. Intravenous infusion terminated 3 of 7 animals between day 30 and 40 of pregnancy. Progestin levels were usually depressed within 24-48 hr after the initial administration of prostaglandin, whereas uterine contractility was increased within 20-30 min. Prostaglandin E2 was about 10 times as potent as PGF2agr in causing uterine contractions; intravenous infusion of 0.8 and 8.0 µg/min, respectively, caused maximal uterine contractions during the latter half of pregnancy. The realtionship of these compounds to normal pregnant uterine physiology in the human and rhesus monkey is discussed.

Submitted on April 13, 1970







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1970 by the Society for the Study of Reproduction.